Dr. Maria Ermolaeva
Group Leader
No one should have to face frailty or cognitive decline in later life.
At the Ermolaeva Laboratory, we work to prevent this outcome. We aim to identify interventions that enhance the resilience of cells and tissues across the lifespan, thereby extending the disease-free period of life and preserving health for as long as possible.
On October 22, a Georgian delegation visited the FLI to explore Thuringia’s life sciences sector, learn about research on aging, and discuss potential collaborations in healthcare and technology.
Dr. Prerana Shrikant Chaudhari, postdoctoral researcher at the FLI in Jena, receives €100,000 in federal funding for the development of the first pharmacological treatment for leaky gut syndrome.
The Leibniz Lab “Pandemic Preparedness: One Health, One Future” connects excellent interdisciplinary and transdisciplinary research. The Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) in Jena is involved by sending three renowned researchers for this purpose. The common goal: to better protect society in future pandemics.
Dr. Maria Ermolaeva from the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) in Jena has received the coveted ERC Consolidator Grant from the EU, in the sum of two million euros. The LifeLongFit project, now funded for the next five years, is looking at ways to contribute to healthier aging through the influence of mild stress.
